HeartSciences Change in Inventories 2022-2025 | HSCS

HeartSciences change in inventories from 2022 to 2025. Change in inventories can be defined as the increase or decrease in a company's inventories for the period.
HeartSciences Annual Change in Inventories
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.000B
Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.399B 58.01
Hims & Hers Health (HIMS) United States $11.729B 121.86
Tempus AI (TEM) United States $9.423B 0.00
IRhythm Technologies (IRTC) United States $4.541B 0.00
Inspire Medical Systems (INSP) United States $4.078B 63.71
Privia Health (PRVA) United States $2.749B 187.92
Enovis (ENOV) United States $1.831B 10.21
Clover Health Investments (CLOV) United States $1.593B 0.00
Schrodinger (SDGR) United States $1.573B 0.00
Phreesia (PHR) United States $1.454B 0.00
Omnicell (OMCL) United States $1.397B 24.65
Azenta (AZTA) United States $1.251B 58.15
10x Genomics (TXG) United States $1.149B 0.00
Fulgent Genetics (FLGT) United States $0.627B 0.00
Butterfly Network (BFLY) United States $0.601B 0.00
Claritev (CTEV) United States $0.591B 0.00
Talkspace (TALK) United States $0.549B 164.00
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.403B 0.00
TruBridge (TBRG) United States $0.358B 793.67
Outset Medical (OM) United States $0.312B 0.00
Nyxoah SA (NYXH) Belgium $0.266B 0.00
Health Catalyst (HCAT) United States $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
Pulmonx (LUNG) United States $0.129B 0.00
EUDA Health Holdings (EUDA) Singapore $0.128B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.102B 0.00
CareCloud (CCLD) United States $0.090B 3.42
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00